Abstract The P2X4 receptor is an ATP-gated ion channel expressed in neurons, endothelia and immune cells. Plasma membrane expression of P2X4 is regulated by dynamindependent endocytosis, and this study identifies a Rab5-dependent pathway of receptor internalisation. Expression of Rab5 constructs altered the distribution of P2X4 in HEK-293 cells, and both constitutive internalisation and agonist-induced desensitisation of P2X4 were increased by co-expression of wild-type Rab5 or constitutively active Rab5 (Q79L). Expression of inactive dynamin K44A and Rab5 S34N constructs abolished agonist-induced desensitisation, suggesting internalisation as the underlying mechanism. Blocking P2X4 internalisation in this way also abolished potentiation of ATP-induced currents by the allosteric modulator ivermectin. This suggests that the dynamin-Rab5 internalisation pathway is essential for the ivermectin potentiation effect. In agreement with this hypothesis, the co-expression of wild-type dynamin, wild-type Rab5 or active Rab5 (Q79L) could increase the potentiation of the ATP-induced P2X4 response by ivermectin. These findings highlight Rab5 GTPase as a key regulator of P2X4 receptor cell surface expression and internalisation.
Introduction
P2X receptors are a family of seven non-selective cation channels (P2X1-7) gated by extracellular ATP [1, 2] . The P2X4 receptor (P2X4) is widely expressed with highest levels in neurons, endothelia, epithelia and both macrophages and microglia. Studies using the P2X4 knockout mice have postulated a role for this receptor in endothelial vascular remodelling [3] , in long-term potentiation in the hippocampus [4] and in neuropathic pain [5] . Ivermectin is an allosteric modulator of P2X4 [6] in addition to other ligand-gated ion channels including mammalian α7-nicotinic receptors, GABA A receptors and glycine receptors [7] [8] [9] . It is thought that ivermectin either increases the number of cell surface P2X4 to increase current amplitude [9] or interacts with the transmembrane regions of P2X4 causing rearrangements which stabilise the channel in the membrane [10] .
Plasma membrane expression of P2X4 is controlled by the AP-2/clathrin-dependent endocytic pathway through a tyrosine-based internalisation motif in the C-terminus [9, 11] . Constitutive cycling of membrane proteins is a mechanism employed by cells to rapidly regulate surface expression of receptors and channels [12] . This is particularly important in the central nervous system where modulation of trafficking of ionotropic receptors underlies long-term potentiation and depression of synaptic activity. In macrophages, the surface expression of the P2X4 is kept low with ATP-induced P2X4-dependent inward currents~1-2 mean current density (pA/pF) despite high levels of intracellular protein [13] , and P2X4 may be sequestered in intracellular compartments such as lysosomes until required at the cell surface [13, 14] .
Endocytosis through the clathrin pathway is typically dependent on the activity of dynamin GTPase which functions to promote membrane invagination and the scission of vesicles from the plasma membrane into the endocytic pathway [15] . Rab proteins are a family of Ras-like small GTPbinding proteins playing important roles in membrane transport and fusion. Rab5 is thought to play a role in sequestering ligands into clathrin-coated pits and to be involved in homotypic endosome fusion [16, 17] . Early endosomes are highly dynamic and comprise at least two populations of vesicles involved in sorting of cargo proteins to different cellular compartments including recycling versus degradation pathways [18] . Rab5 is known to play a role in regulating endocytosis of G-protein-coupled receptors such as EGF and insulin receptors [19, 20] and the Kv1.5 channel [21] and drives the NMDA receptor-mediated internalisation of AMPA receptors in neurons [22] .
This study investigated constitutive and agonist-induced internalisation pathways for P2X4 expressed in mammalian HEK-293 cells to determine key regulators of plasma membrane expression. Dynamin plays a key role in both constitutive and agonist-induced internalisations, whereas Rab5 plays a small but significant role in P2X4 internalisation. However, this Rab5-dependent pathway is critical for potentiation of P2X4 responses by ivermectin. Therefore, Rab5 is a key protein involved in regulating the trafficking of the P2X4.
Methods

Cells
HEK-293 cells were maintained in DMEM/F12 medium (Invitrogen, San Diego, CA, USA) containing 10 % foetal calf serum (FCS) and 2 mML-glutamine (Invitrogen, San Diego, CA, USA) at 37°C in a humidified 5 % CO 2 incubator. Confluent cells were transiently transfected in 35-mm Petri dishes with 0.1 μg rat P2X4-green fluorescent protein (GFP) in pShuttle vector together with 1 μg of wild-type or dominant negative K44A HA-tagged dynamin GTPase using Lipofectamine 2000 (Invitrogen, San Diego, CA, USA) as per manufacturer's instructions. Myc-tagged wild-type Rab5, constitutively active Q79L Rab5 or inactive S34N Rab5 constructs were a kind gift from Professor Elizabeth Smythe, University of Sheffield, UK. Post-transfection (24 h) cells were plated onto 13-mm glass coverslips for electrophysiology and immunofluorescence experiments.
NR8383 rat alveolar macrophage cell line were cultured as described previously [13] . Briefly, NR8383 cells were maintained in F12K media (Invitrogen, San Diego, CA, USA) supplemented with 15 % FCS at 37°C in a humidified 5 % CO 2 incubator and were subcultured by scraping.
Electrophysiology
Whole-cell patch-clamp recordings were performed at room temperature using a HEKA EPC9 amplifier and Pulse acquisition software (HEKA, Lambrecht, Germany). Agonist and the allosteric modulator ivermectin (3 μM) were delivered using the RSC-160 fast-flow system (BioLogic Science Instruments, France). Unless otherwise stated, internal/external solutions were NaCl 145 mM, N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES) 10 mM, EGTA 10 mM/NaCl 145 mM, KCl 2 mM, CaCl 2 2 mM, MgCl 2 1 mM, HEPES 10 mM and glucose 13 mM; pH7.3, osmolarity 300-310 mOsmol/l. Holding potential was −60 mV.
Immunofluorescence and confocal microscopy HEK-293 cells transfected with P2X4-GFP plus Rab5 or dynamin constructs were grown on 13-mm glass coverslips. Cells were fixed with 2 % paraformaldehyde solution at 4°C for 20 min. Excess fixative was removed by washing three times with phosphate-buffered saline (PBS). Cells were permeabilised using 0.1 % saponin (Sigma, St. Louis, MO, USA) in PBS containing 5 % FCS, and primary antibody was diluted in this buffer for staining. Anti-myc antibody (Covance Inc., Princeton, New Jersey, USA) was used at 1:500 dilution, and anti-HA antibody (Sigma, St. Louis, MO, USA), at 1:5,000 dilution. Staining with primary antibodies was performed for 1 h at room temperature. Cells were then washed three times in PBS (5 min per wash). Cells were incubated with antimouse IgG Alexa 594 (Molecular Probes, Invitrogen, San Diego, CA, USA) at 1:100 dilution in 0.1 % saponin/PBS/ FCS for 1 h at room temperature. Excess antibody was removed by three washes in PBS. Coverslips were mounted onto glass slides with Prolong Gold antifade (Molecular Probes, Invitrogen, San Diego, CA, USA). Images were acquired on a Zeiss LSM 510 Meta confocal microscope using a×63 oil-immersion objective.
Surface biotinylation and western blotting NR8383 cells (5×10 7 ) were plated into 60-mm Petri dishes in complete media 24 h prior to stimulation. Cells were treated with vehicle or ivermectin (3 μM) for 5 min and washed once with PBS. An aliquot of 4 ml of 0.5 mg/ml EZ-Link Sulfo-NHS-LC-Biotin (Pierce, Perbio Science UK, Ltd.) was added to each sample for 30 min at room temperature on a rotating wheel. Glycine was added to quench the reaction, and cells were centrifuged and lysed in 2 % Triton X-100 lysis buffer containing complete protease inhibitors (Roche, UK). Protein was measured using Bio-Rad Protein Assay (BioRad, Hercules, CA, USA), and equal amounts of protein were incubated with streptavidin beads (Pierce, Perbio Science UK, Ltd.) overnight at 4°C to pull down all biotinylated proteins. Beads were washed four times and boiled in gel sample buffer to release biotinylated proteins. Equal amounts of biotinylated protein were loaded per lane and electrophoresed on 8 % SDS-PAGE gels. Protein was transferred to PVDF membranes (Sigma, St. Louis, MO, USA) and blocked overnight at 4°C with 5 % non-fat milk. Rabbit anti-P2X4R C-terminal antibody (Alomone Labs, Jerusalem, Israel) and rabbit anti-β-actin (Abcam, Cambridge, UK) were both used at 1:2,000 dilution.
Anti-Rab5 (BD Pharmingen, San Diego, CA, USA) was used at 1:250 dilution. HRP-conjugated goat anti-rabbit and anti-mouse secondary antibodies (Dako, Denmark) were used at 1:2,000 dilution. Western blots were developed using ECL plus kit (GE Healthcare, Amersham, Buckinghamshire, UK) and Kodak Bio-Max MS film (Sigma, St. Louis, MO, USA).
Results
Dynamin controls both constitutive and agonist-induced internalisations of P2X4
It has previously been reported that the constitutive internalisation of P2X4 heterologously expressed in neurons is dependent on dynamin [23] and that receptor internalisation is mediated via the AP-2/clathrin-dependent pathway in the Xenopus oocyte expression system [11] . The dependence of P2X4 plasma membrane localisation on dynamin GTPase activity was assessed by studying the distribution of green fluorescent protein-tagged P2X4 transiently transfected into HEK-293 cells when either wild-type dynamin (Dyn-WT) or the dominant negative mutant dynamin K44A GTPase (Dyn-K44A) was co-expressed. Confocal images in Fig. 1a show that the distribution of P2X4-GFP in HEK-293 cells was predominantly intracellular in punctate structures, and that co-expression with Dyn-K44A changed this distribution to a more uniform plasma membrane localisation similar to that previously reported in neurons [23] . Co-expression of Dyn-WT with P2X4-GFP increased the punctate nature of the receptor distribution and reduced the plasma membrane localisation of the receptor (Fig. 1a) . To quantitate this effect of dynamin co-expression on P2X4 plasma membrane localisation, ATP-induced inward currents were recorded from HEK-293 cells expressing P2X4-GFP alone or in combination with dynamin constructs, and representative electrophysiological recordings are shown in Fig. 1b . The normalised mean current density in cells expressing P2X4-GFP alone was 173.8±14.0 pA/pF (n019 cells), whereas coexpression of Dyn-WT significantly reduced the mean current density of the ATP-induced response to 68.1±8.8 pA/pF (n011 cells, p<0.0001) (Fig. 1c) . Thus, over-expression of dynamin reduces surface expression of P2X4 by approximately 60 % in these cells. Despite a dramatic alteration in distribution of the GFP-tagged P2X4 when Dyn-K44A was co-expressed, there was only a slight increase in the mean current density of the ATP-induced response (193.3±19.8 pA/pF, n09 cells compared to control 173.8±14.0 pA/pF, n019 cells), which was not statistically significant. Increasing the expression of Dyn-WT can therefore limit the expression of the P2X4 at the cell surface of HEK-293 cells, suggesting that dynamin controls constitutive internalisation of the P2X4. and localisation of dynamin-HA proteins using an anti-HA antibody (bottom panels). Cells were stained with anti-HA primary antibody followed by antimouse IgG TRITC secondary antibody. Images were acquired using a Zeiss LSM510 confocal microscope and a×63 oil-immersion objective and are representative of three separate transfection experiments. b Representative inward currents in response to 10 μM ATP in cells expressing P2X4-GFP alone, P2X4-GFP plus wild-type dynamin or P2X4-GFP plus dynamin K44A mutant. Electrophysiological recordings were performed 24-48 h post-transfection. ATP was applied for 5 s as shown by the black bar. c Bar chart shows that co-expression of Dyn-WT significantly reduced the ATPinduced P2X4 mean current density (pA/pF) compared to P2X4-GFP receptors alone (*p<0.0001; n09-19 cells). Error bars represent SEM Desensitisation during the ATP-induced inward current mediated by the P2X4 is a known characteristic feature of this receptor determining the time course and magnitude of ATP action. Desensitisation was calculated as the percentage decline in the response during agonist application by measuring current amplitude 4 s after the peak of the response as described by Fountain and North [24] . The co-expression of Dyn-K44A markedly reduced desensitisation of the ATPinduced P2X4 response (Fig. 2a) . Typically, the ATP-induced P2X4 response declined by an average of 32.7±2.9 % (n016 cells), but co-expression of Dyn-K44A abolished the decline in response to 4.1±2.1 % (n09 cells, p<0.0001; Fig. 2b ).
Desensitisation during the agonist application was not affected by co-expression with Dyn-WT (mean decline in response 30.0±4.1 %, n011 cells; Fig. 2b ). This suggests that P2X4 desensitisation is mediated by a dynamin-dependent agonist-induced internalisation.
Expression of Rab5 mutants alter the distribution and internalisation of P2X4
Rab5 is a rate-limiting enzyme involved in clathrin-dependent endocytosis pathways responsible for trafficking proteins from the plasma membrane to early endosomes. Two mutant a b
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Images were acquired using a Zeiss LSM510 confocal microscope and a×63 oil-immersion objective and are representative of three separate transfection experiments. Expression of Rab5 WT or Rab5 Q79L induces an enlarged endosomal compartment that is stained with GFP and anti-myc GTPases, a constitutively active GTP-bound Rab5 enzyme (Rab5 Q79L) and an inactive GDP-bound GTPase (Rab5 S34N), were used to determine whether Rab5 could regulate P2X4 surface expression. The effect of co-expression of wildtype Rab5 (Rab5 WT), Rab5 Q79L or Rab5 S34N on the distribution of GFP-tagged P2X4 in HEK-293 cells was assessed. Figure 3 shows that the expression of Rab5 WT or Rab5 Q79L formed an enlarged endosomal compartment containing GFP fluorescence and therefore containing P2X4. An increase in Rab5 expression (Rab5 WT) or Rab5 activity (Rab5 Q79L) increased the endosomal localisation of P2X4 (Fig. 3) . Rab5 S34N was found to alter the intracellular distribution of P2X4-GFP similar to the dominant negative Dyn-K44A mutant, showing a less punctate, more uniform surface localisation (Fig. 3) . Next, ATP-induced inward currents were recorded to investigate to what extent Rab5 affected constitutive and agonist-induced internalisation pathways of P2X4. Figure 4 shows that the expression of Rab5 WT or Desensitisation or agonist-induced internalisation was measured as percentage decline in peak amplitude of the response, and Fig. 4b shows that the co-expression of Rab5 Q79L and Rab5 S34N altered the extent of desensitisation. Rab5 Q79L increased the decline in the response (average percentage decline 40.9±1.7 %, n016 cells compared to 32.7±2.9 %, n016 cells for control P2X4-GFP alone; p<0.05), whereas Rab5 S34N slowed the decline in the response to an average of 23.1±3.35 % (n09 cells, p<0.05). This suggested that a Rab5-dependent component plays a role in agonist-induced internalisation of P2X4 but is not the major regulator of agonist-induced dynamin-dependent internalisation.
Ivermectin potentiation of P2X4 requires internalisation
It has previously been suggested that clathrin-dependent endocytosis is required for potentiation of P2X4 responses by the allosteric modulator ivermectin (IVM) [9] . The requirement for endocytosis pathways in potentiation was investigated using co-expression of dynamin and Rab5 mutants which affect constitutive and agonist-induced internalisations to varying degrees. The I IVM /I control (peak amplitude of ATP response after ivermectin/peak amplitude of ATP response before ivermectin) was measured as a percentage. Coexpression of Dyn-K44A significantly reduced ivermectin potentiation to 138±7 % (n08 cells, p<0.0001) compared to 244±17 % (n016 cells) in cells expressing P2X4-GFP alone, a reduction of approximately 50 %. Conversely, co-expression of Dyn-WT increased the magnitude of ivermectin potentiation to 316±27 % (n010 cells, p<0.05) (Fig. 5) . Similarly, coexpression of Rab5 S34N with P2X4 reduced the potentiation by ivermectin to 158±14 % (n010 cells, p00.0008), and Rab5 WT or Rab5 Q79L increased the potentiation by ivermectin to 359.3±5.4 % (n014 cells) and 429±4.9 % (n016 cells, p00.0024), respectively (Fig. 6) . Together, these data show that internalisation through the Rab5-dependent pathway is required for potentiation of P2X4 by ivermectin.
In macrophages, P2X4 receptor cell surface expression is kept low (~1 pA/pF) despite high levels of protein expression [13] , and ivermectin potentiates P2X4 responses by approximately fivefold [13, 14] . It is known that Rab5 and dynamin GTPases are expressed in macrophages [25, 26] , and Fig. 7a confirms the expression of Rab5 protein in NR8383 cells. There are no suitable antibodies available to the ectodomain of P2X4; therefore, to show that ivermectin affects internalisation and trafficking of P2X4 receptors in macrophages, surface biotinylation was used. Figure 7b demonstrates increased surface expression of endogenous P2X4 receptors in the presence of ivermectin for 3 min.
Discussion
In this study, previous work showing that endocytosis of the P2X4 was dynamin dependent has been confirmed, and Rab5 has been identified as a key regulator of P2X4 surface expression. The internalisation of P2X4 is thought to be mediated via clathrin-dependent endocytosis through an AP-2 subunit interaction with a non-canonical tyrosine-based motif in the Cterminus [11] . Much of the previous work on the trafficking of P2X4 has been performed in a Xenopus oocyte expression system rather than in mammalian cells [9, 11] . Here, a GFPtagged P2X4 was expressed in mammalian HEK-293 cells to identify proteins important in the regulation of cell surface expression and endocytosis of P2X4. Dynamin GTPase is essential for the pinching off of vesicles from the plasma membrane into the endocytic recycling and degradation pathways. The K44A mutation in dynamin abolishes the GTPase activity of dynamin and blocks clathrin-dependent endocytosis [27] . The co-expression of Dyn-K44A with P2X4 altered the cellular distribution of P2X4, although no significant increase in mean current density of the ATP-induced inward current was found (Fig. 1) . This is likely to be because P2X4 is already expressed at a high receptor density (160-180 pA/pF) in HEK-293 cells possibly due to the reduced lysosomal localisation of P2X4 in this cell line [14] . Bobanovic et al. showed that Dyn-K44A could increase the functional expression of P2X4 in neurons; however, the mean current density of P2X4-GFP was much lower in these cells (20- the Dyn-WT construct reduced the mean current density of ATP-induced P2X4 responses by approximately 60 %, suggesting that less P2X4 was present at the cell surface to respond to ATP. It has been demonstrated that macrophages express a small number of P2X4 at the cell surface [13, 14, 28] with a normalised mean current density of only 1-2 pA/pF [13] . Macrophages are known to have high rates of endocytosis [29] and rapidly turn over their repertoire of cell surface receptors. Expression of dynamin 2 in macrophages [25] may contribute to the limited surface expression of P2X4. Rab5 is a rate-limiting enzyme responsible for trafficking proteins from the plasma membrane to early endosomes during clathrindependent endocytosis [17] , and over-expression of WT Rab5 or constitutively active Rab5 (Q79L) reduced the number of P2X4 available at the surface for activation by ATP by approximately 30 % (Fig. 4) . Therefore, by increasing expression or activation of Rab5, the cell could regulate surface P2X4 density through modulation of endocytosis. It is known that macrophages express an abundance of Rab5 where, in addition to endocytosis, Rab5 plays a role in phagocytosis and regulates phagosome maturation [26] . In addition to the regulation of constitutive internalisation of P2X4 and, therefore, availability of surface receptors for agonist binding, dynamin also controls agonist-induced desensitisation of P2X4. Desensitisation was measured as described in Fountain and North [24] , and it was found that desensitisation was almost completely abolished when dynamin K44A was co-expressed with P2X4 ( Fig. 2) and was slowed by co-expression with Rab5 S34N (Fig. 4) , suggesting that internalisation through the clathrin-dependent endocytic pathway is responsible for desensitisation. Fountain and North identified a C-terminal lysine residue, K373 and an adjacent tyrosine residue Y374 which, when mutated to alanine, both accelerated desensitisation [24] . These residues are close to the predicted internalisation motif YEQGL [11] and may affect the binding of endocytic proteins to this C-terminal region to allow faster internalisation. Desensitisation is important for determining the duration and, therefore, magnitude of the P2X4-induced signal, and this may contribute to downstream signalling events associated with P2X4 activation such as calcium influx, MAPK activation and secretion of brainderived neurotrophic factor (BDNF) and prostaglandin E 2 (PGE 2 ) [5, 30] . P2X4 is highly permeable to calcium [31] , and the extent of desensitisation will regulate the spatial and temporal signalling aspects of both global and local calcium increases. An increase in expression or activity of Rab5 could increase agonist-induced internalisation, and this may be one mechanism by which cells can reduce signalling through P2X4. Despite the differences seen in regulation of constitutive and agonist-induced internalisations of P2X4 by dynamin and Rab5, the effect of ivermectin potentiation of P2X4 responses were similar. Co-expression of Dyn-WT, Rab5-WT or active Rab5 significantly increased the potentiation by ivermectin, whereas inactive dynamin or Rab5 almost abolished ivermectin potentiation. Toulmé et al. have shown that ivermectin can increase the fraction of P2X4 associated with the plasma membrane in a Xenopus oocyte system and that disruption of clathrin-dependent endocytosis with membrane proximal dominant negative AP-2 or Eps15 proteins abolished potentiation by ivermectin [9] . The presented hypothesis suggested that internalisation of P2X4 was required for the increased ATP-induced response measured following treatment of the cell with ivermectin. Conversely, Silberberg et al. found that ivermectin did not increase the surface biotinylated fraction of P2X4 in the Xenopus oocyte system, thus challenging the hypothesis that endocytosis is required for ivermectin potentiation. Instead, Silberberg et al. proposed that ivermectin stabilises the receptor protein in the membrane in the open channel conformation [10] . The results with dynamin and Rab5 constructs would seem to favour the first hypothesis, but it is possible that the two hypotheses do complement each other. The fraction of P2X4 in the rapidly recycling endosomal pool likely dictates the number of P2X4 at the cell surface available for agonist binding. This study shows that altering the expression of key regulatory endocytic proteins can modulate cell surface expression by altering P2X4 turnover. The binding of ivermectin to P2X4 transmembrane regions may stabilise the protein in the membrane and prevent constitutive internalisation. Due to the continual insertion of P2X4-containing vesicles from the endosomal pool, this, in combination with blocked internalisation of ivermectin-bound P2X4, would increase the total number of P2X4 available for binding ATP, resulting in an increased response. Furthermore, surface biotinylation experiments in NR8383 macrophages demonstrate that ivermectin does increase the amount of P2X4 protein at the cell surface (Fig. 7) .
P2X4 has recently been implicated in the pathology of neuropathic pain due to induction of BDNF secretion from spinal microglial cells [5] and inflammation-induced pain via secretion of the inflammatory mediator PGE 2 [30] . The cell surface expression of P2X4 appears to be tightly regulated in macrophages and microglia through both constitutive cycling and lysosomal targeting, and it has been shown that upregulation of P2X4 at the plasma membrane could be achieved by lysosomal exocytosis, phagocytosis of foreign particles or by altering endocytosis [13, 14] . This study provides new information about the regulation of constitutive and agonist-induced internalisation pathways of P2X4 and highlights Rab5 as a key protein controlling P2X4 trafficking.
